Get the SPI Wire

BIOVIE INC.

NASDAQ:BIVI
Annual Meeting

of Shareholders

MEETING DATE

11/10/2026
DEF 14A FILED
09/28/2026
PUBLISHED
09/28/2026 9:13 pm
TIME TO PUBLISH
09/30/2026
METHODOLOGY
approve
EXCHANGE NASDAQ:BIVI· CUSIP 09074F504 · CLASS common stock · CIK 0001580149

RECONCILED · MIXED

Reconciled against the company’s Form 8-K Item 5.07 filed 2026-06-15.

3
FOR
0
AGAINST
0
WITHHOLD
3
BALLOT ITEMS

ITEM-BY-ITEM RECOMMENDATIONS

1
Election of six directors
board
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

The filing states the Board unanimously recommends a vote for each nominee.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
2
Ratification of appointment of EisnerAmper LLP as independent registered public accounting firm for the fiscal year ending June 30, 2027
auditor
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

The Audit Committee received EisnerAmper's independence disclosures and discussed its independence.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
3
Approval of an amendment and restatement of the 2019 Omnibus Equity Incentive Plan to increase shares available from 399,509 to 3,100,000
compensation
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

The filing states only 399,509 shares remained available under the plan as of September 21, 2026.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.

Ledger

5ce135d5013444cc9edd7265b4d3c64ed9b69fade116dda2e927abea0f43d398

Search company, ticker, executive, director or issue

    The SPI Wire · Proxy Intelligence

    Get every ballot call, before the vote.

    FOR, AGAINST or WITHHOLD on each covered ballot item — published within 48 hours of the definitive proxy filing. Follow the companies you own, or take the full feed.




    Pick the companies you own — you’ll only hear from us on their ballots.

    The SPI Wire covers proxy ballots only — it has nothing to do with Signal Research investigations. Research and analysis for informational purposes; not legal, investment, or voting advice. Unsubscribe anytime.

    Submit Information








      Join Monitoring List




        Receive Research Updates